RESEARCHER PROFILE
Professor Divya Mehta, Principal Research Fellow
Stress Genomics Laboratory, School of Biomedical Sciences
QUT (Queensland University of Technology), Australia
Understanding the interaction between genes and lifestyle factors in response to stress can lead to potential therapeutic interventions for stress-related disorders. This research is crucial for promoting health and well-being.
Professor Divya Mehta works as a Principal Research Fellow at the Stress Genomics Laboratory, in QUT (Queensland University of Technology) in Australia, specialising in stress genomics and mental health. Her education started in the UK with undergraduate and Masters, followed by her PhD in Germany and postdoctoral at Max Planck Institute of Psychiatry. 11 years ago Professor Mehta moved to Australia.
Her focus is research is understanding how genes and lifestyle factors interact to drive our response to stress, particularly in emergency responders, veterans, and elite athletes, with a focus on epigenetics.
Epigenetics are the dynamic part of our DNA, that change across our lifetime in response to stress, exercise, social support, and nutrition, impacting our overall health.
Social support can reduce and reverse negative impacts of stress on genes, leading to potential therapeutic interventions for stress-related disorders.
Research at the intersection of statistics, genomics, and mental health can provide valuable insights into the devastating impact of mental health disorders on individuals, families, and communities.
Professor Mehta has recently commenced research into elite athlete physical and mental health impact performance, with research at the intersection of statistics, genomics, and mental health. This research is ahead of, and in anticipation of, the Summer Olympics in Brisbane in 2032.
Understanding the drivers of health and well-being is crucial for ensuring a happy and healthy life, which is Professor Mehta’s passion. Outside of the work environment, she also enjoys sports, volunteering for animal rescue, and spending time with family.
-
Infections and other lung diseases using models of human lung tissue grown from stem cells
Dr Rhiannon Werder is a Team Leader at Murdoch Children’s Research Institute leading a multidisciplinary team, combining expertise in stem cell biology and immunology, to develop new therapies for lung diseases. Her research centres around induced pluripotent stem cells to investigate respiratory diseases, spanning acute respiratory infections to chronic lung diseases. Using stem cells, Dr Werder’s team creates models of human lung tissue. With these models, Dr Werder is investigating how human-specific pathogens infect different regions of the lung, the ensuing immune responses, and how the lung repairs itself after infections, especially in people with preexisting lung diseases.
-
Lymphoma, Myeloma and Genomics
Professor Dipti Talaulikar is a clinical and laboratory haematologist with expertise in genomics, working at Canberra Health Services, and Professor at ANU. She has a clinical and research interest in lymphoma, myeloma and genomics, and has authored close to 100 peer reviewed papers, including several clinical guidelines that have had a significant impact on clinical practice.
-
Next Generation Condom Contraception, Dr David Shepherd
Dr David Shepherd is a Lead Production Engineer and Materials Specialist at Eudaemon Technologies. His journey began at the University of Wollongong, where he pursued advanced studies and eventually obtained a PhD under the guidance of a distinguished professor. His research initially focused on actuating materials and artificial muscles, particularly centred around hydrogel materials. These early explorations have seamlessly evolved into his current focus on utilising hydrogels in the realm of sexual reproductive health, with a specific emphasis on developing innovative hydrogel condoms.
